Hospital medicine in the UK is under unprecedented pressure, with increasing demand on physicians as well as challenges in recruiting new doctors into the physicianly specialties. We sought to assess the prevalence of the afternoon ward round and its effect on those undertaking them. We sampled each hospital within our postgraduate region, surveying junior doctors working on inpatient medical wards. We surveyed roughly two-thirds of eligible doctors, fi nding that 30% of juniors had some commitment, of varying frequency, to ward rounds beginning after 1.00pm. Of the doctors involved in afternoon ward rounds, the majority felt they contributed to late fi nishes, delayed discharge of patients, reduced team effi ciency and reduced job satisfaction. Just under 80% felt they were less likely to consider a career in hospital medicine as a result The afternoon ward round lives on, and we should not underestimate its effect. Low junior doctor morale coupled with high work intensity can lead to burnout as well as impairing the effectiveness of the clinical service. Clinical leaders should consider leaving this practice in the past so we can cope with the challenges of the future.

No abstract

Purpose of review Outcomes for patients with advanced lung cancer have traditionally been very poor. This patient group are often comorbid, less fit and experience multiple symptoms. This review discusses strategies for minimizing the impact of cachexia on patients with advanced lung cancer. This is timely, as in recent years there has been a rapid increase in available systemic therapy options, with the potential of long-term survival for some patients. Recent findings The review discusses current strategies in combating cachexia, including: symptom control, systemic therapy for cancer and for cachexia, nutritional interventions and exercise interventions. It discusses current clinical trials, combining interventions and the paradigm of prehabilitation. Summary It is likely that the optimal way of minimizing the impact of cachexia in advanced lung cancer is through a combination of early interventions including symptom management.

No abstract

No abstract